| Item type: | Article | ||||
|---|---|---|---|---|---|
| Journal or Publication Title: | Revista Española de Cardiología | ||||
| Publisher: | EDICIONES DOYMA S A | ||||
| Place of Publication: | BARCELONA | ||||
| Volume: | 72 | ||||
| Number of Issue or Book Chapter: | 2 | ||||
| Page Range: | pp. 145-153 | ||||
| Date: | 2019 | ||||
| Institutions: | Medicine > Lehrstuhl für Herz-, Thorax- und herznahe Gefäßchirurgie | ||||
| Identification Number: |
| ||||
| Keywords: | BUNDLE-BRANCH BLOCK; AORTIC-VALVE; SAPIEN 3; CONSENSUS DOCUMENT; CLINICAL-OUTCOMES; REPLACEMENT; GENERATION; EXPERIENCE; SYSTEM; DEPTH; Transcatheter aortic valve implantation; Conduction abnormalities; Permanent pacemaker implantation; Predictors | ||||
| Dewey Decimal Classification: | 600 Technology > 610 Medical sciences Medicine | ||||
| Status: | Published | ||||
| Refereed: | Yes, this version has been refereed | ||||
| Created at the University of Regensburg: | Yes | ||||
| Item ID: | 49017 |
Web of ScienceAbstract
Introduction and objectives: The incidence of permanent pacemaker implantation (PPI) and new conduction abnormalities (CA) with the ACURATE neo (Symetis S.A., Eclubens, Switzerland) has not been studied in detail. We aimed to analyze their predictors, evaluating patient- and device-related factors, including implantation depth and device-to-annulus ratio (DAR). Methods: Two analyses of a ...
Abstract
Introduction and objectives: The incidence of permanent pacemaker implantation (PPI) and new conduction abnormalities (CA) with the ACURATE neo (Symetis S.A., Eclubens, Switzerland) has not been studied in detail. We aimed to analyze their predictors, evaluating patient- and device-related factors, including implantation depth and device-to-annulus ratio (DAR). Methods: Two analyses of a multicenter population were performed: new PPI in pacemaker-naive patients (n = 283), and PPI/new-CA in patients without prior CA or pacemaker (n = 232). Results: A new PPI was required in 9.9% of patients, who had a higher body mass index, higher rate of right bundle branch block and bradycardia. Neither implantation depth nor DAR differed in patients with PPI compared with those without. In the multivariable analysis neither DAR (OR, 1.010; 95%CI, 0.967-1.055; P = .7) nor implantation depth (OR, 0.972; 95%CI, 0.743-1.272; P = .8) predicted PPI. Only high body mass index, bradycardia and right bundle branch block persisted as independent predictors. PPI/ new-onset CA occurred in 22.8% of patients and was associated with a higher logistic EuroSCORE. Neither implantation depth nor DAR differed in patients with PPI/new-CA vs those without (7.3 +/- 1.9 vs 7.1 +/- 1.5 mm; P = .6 and 41.0 +/- 7.9 vs 42.2 +/- 10.1%; P = .4). The only predictor of PPI/new-CA was a higher logistic EuroSCORE (OR, 1.039; 95%CI, [1.008-1.071]; P = .013). Conclusions: New PPI and new-onset CA rates were low with the ACURATE neo. These were mainly influenced by patient characteristics and not by device-depending factors. (C) 2018 Sociedad Espanola de Cardiologia. Published by Elsevier Espana, S.L.U. All rights reserved.
Metadata last modified: 03 Sep 2021 10:04
Altmetric